Publications

5803 Results

Evaluating the Utility and Privacy of Synthetic Breast Cancer Clinical Trial Data Sets

Authors
S El Kababji;N Mitsakakis;X Fang;A Beltran-Bless;G Pond;L Vandermeer;D Radhakrishnan;L Mosquera;A Paterson;L Shepherd;B Chen;W Barlow;J Gralow;M Savard;M Clemons;K El Emam
Journal / Conference
JCO Clinical Cancer Informatics Sep;7:e2300116. doi: 10.1200/CCI.23.00116
Year
2023
Research Committee(s)
Breast
PMID
PMID38011617
PMC
PMC10703127
Study Number(s)
S0307

DEVELOPMENT AND TESTING OF A CUSTOM NANOSTRING RNA CODESET FOR MUSCLE-INVASIVE BLADDER CANCER UTILIZING TCGA SUBTYPING (SWOG S1011)

Authors
SR Patel;M Anurag;MS Lucia;J Meeks;D McConkey;J Kim;C Tangen;S Lerner
Journal / Conference
SUO (Society of Urologic Oncology) (Nov 28-Dec 1, Washington, DC), poster #73
Year
2023
Research Committee(s)
Genitourinary
Study Number(s)
S1011

Physical Activity in Recurrent Colon Cancer: CALGB/SWOG 80702 (Alliance)

Authors
J Brown;C Ma;Q Shi;T Zemla;F Couture;P Kuebler;P Kumar;B Tan;S Krishnamurthi;R Goldberg;A Venook;CD Blanke;E O'Reilly;A Shields;J Meyerhardt
Journal / Conference
Journal of the National Cancer Institute
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID37651160
PMC
PMC10843498
Study Number(s)
CTSU/C80702

A Ground’s Eye View on Racial and Ethnic Disparities in Cancer Clinical Trial Participation

Journal / Conference
JAMA Netw Open. 2023 Jul 3;6(7):e2322436
Year
2023

Lost in Translation: The Participation in Cancer Clinical Trials for Patients with Limited English Proficiency

Journal / Conference
J Natl Compr Canc Netw. 2023 Jan;21(1):99-100
Year
2023

Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis

Journal / Conference
Int J Epidemiol, 52(1), 71-86
Year
2023

Common Methods of Determining Meaningful Change in Clinical Practice: Implications for Precision Patient-Reported Outcomes

Journal / Conference
Qual Life Res. 2023 May;32(5):1231-1238
Year
2023

Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention Trial

Authors
S Chadid;X Song;J Schenk;B Gurel;MS Lucia;I Thompson, Jr.;M Neuhouser;P Goodman;H Parnes;S Lippman;W Nelson;A De Marzo;E Platz
Journal / Conference
Nutrition and Cancer 74(1):141-148
Year
2022
Research Committee(s)
Cancer Control
PMID
PMID33511883
PMC
PMC8319215
Study Number(s)
SWOG-9217

Genome-wide association studies of survival in 1,520 cancer patients treated with bevacizumab-containing regimens

Authors
J Quintanilha;J Wang;A Sibley;W Xu;O Espin-Garcia;C Jiang;A Etheridge;M Ratain;H-J Lenz;M Bertagnolli;H Kindler;M Dickler;A Venook;J Liu;K Owzar;D Lin;F Innocenti
Journal / Conference
International Journal of Cancer, Jan 15;150(2):279-289. doi: 10.1002/ijc.33810. Epub 2021 Oct 5
Year
2022
Research Committee(s)
Breast and Gastrointestinal
PMID
PMID34528705
Study Number(s)
CTSU/C40503, CTSU/C80405

A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

Authors
S Adams;M Othus;S Patel;K Miller;R Chugh;S Schuetze;M Chamberlin;B Haley;A Storniolo;K Cawley;M Reddy;S Anderson;C Zimmerman;A O'Dea;M Mirshahidi;J Ahnert;F Brescia;O Hahn;J Raymond;D Biggs;M Thompson;R Connolly;E Sharon;L Korde;R Gray;E Mayerson;M Plets;CD Blanke;YK Chae;R Kurzrock
Journal / Conference
Clinical Cancer Research, Jan 15;28(2):271-278
Year
2022
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID34716198
PMC
PMC8776596
Study Number(s)
S1609